Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of clotrimazole otic solution for fungal otitis externa
2019-003463-22Phase 3Active
- Sponsor
- Laboratorios Salvat, S.A.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in otomycosis comparing Clotrimazole 1% otic solution with Placebo otic solution (2 arms). Primary endpoint: Therapeutic cure at test-of-cure (Visit 4). Started Jan 2020; status: active.
02
Drugs
clotrimazole
03
Conditions
otomycosis
Beyond the preview
Go deeper on 2019-003463-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003463-22.